HealthcareJul 16, 2026

Lupin Pharmaceuticals, Inc.

Company Profile Analysis

Book Demo Subscribe Now

Lupin Pharmaceuticals, Inc. - Healthcare showcase

Year Founded & Workforce

1967-12-31

18,302 Employees

Industry

Healthcare

Services

Lupin Pharmaceuticals, Inc. Overview

Company Headquarters: Mumbai, India

Founded: 1968

Workforce: ~18,302

Company Working: Lupin Pharmaceuticals, Inc., a multinational pharmaceutical company, manufactures and distributes drugs. It develops and produces branded and generic formulations, biotechnology goods, and pharmaceutical active components. The company also maintains a pipeline in high-barrier markets such as Inhalation, Biosimilars, and Complex Injectables. The vast majority of the company's sales are generated in the US, followed by India. In addition, Lupin creates generic drugs with added value using its platform technology. Furthermore, the business runs production facilities in Brazil, Mexico, the US, and India together with its subsidiaries.

Strategy

Lupin Pharmaceuticals, Inc.’s main goal is to drive increased RX share and isolate unmet needs for patients and providers. It also focused on offering access-enhancing features to patients in need. including copay savings programs. In addition, the company also focused on making high-quality biologics affordable and accessible to patients across the globe. Furthermore, also focuses on expanding its market globally by acquiring small companies and collaborating with major players.

Company Snapshot

$2,155.7M

Revenue

18,302

Employees

1967-12-31

Founded

Mumbai, India

Headquarters

SWOT Analysis

Strengths

Wide global footprint as it is present in over 70 countries
Worldwide leader in cephalosporin and anti-TB drugs
Well-built brand portfolio
In the US and Japanese market, it is the largest generic player

Weaknesses

It operates in low-growth segments such as respiratory diseases
High dependence on global formulation business with 84% of revenue coming from the US market

Opportunities

Emerging technological trends in drug delivery
Increasing prevalence of occasional constipation

Threats

Rigid opposition both from locals and global company
Change of government policy
Soaring cost of discovering novel products

Product Offering

Lupin Pharmaceuticals, Inc.
- Polyethylene Glycol 3350

Financial Performance

A plan for every need

Forecast+

Get unlimited access to forecasts, charts, and company data across every research report on Wantstats.

USD200/mo

About the Author

Wantstats Research Team

Wantstats' research desk profiles Lupin Pharmaceuticals, Inc. as part of our ongoing coverage of the Healthcare sector, drawing on public company data, filings, and market intelligence.

Powering the world's best teams.
From next-gen startups to established enterprises.

See our work in action

Start your data driven journey with us!

Book a Demo Now

What our clients say

Trusted by forward-thinking businesses
for data-driven intelligence

Noah Malgeri

Co-Founder, Mojave Rail Fabrication Limited

This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.

Michael Robert

Manager, JavolVision

Thanks, I am so happy that we worked together. Maybe we still can work together in the future.

Joseph Aguayo

Sales Operations & Pricing Manager, Intel

Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.

Bong Lau

Sales Leader, Bamberg

We bought your "2025 report" in 2020. Everything is fine and very good.

Peter Groot Koerkamp

Account and Business Manager, EFS-Holland BV

Thanks for sending the report it gives us a good global view of the Betaïne market.

Younghwan Choi

Senior Retail Manager, LG Chem

We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.

Mark Irwin

Management Consultant, Level 21

I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.

Rob Kooiker

Group Product Manager HVAC & Fire Protection GMA, Rockwool

I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!

Jason Lee

R&D Director, Seojin

Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.

Akif Moroglu

Strategy & Business Development Director, Dogan Holding

We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.

Noah Malgeri

Co-Founder, Mojave Rail Fabrication Limited

This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.

Michael Robert

Manager, JavolVision

Thanks, I am so happy that we worked together. Maybe we still can work together in the future.

Joseph Aguayo

Sales Operations & Pricing Manager, Intel

Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.

Bong Lau

Sales Leader, Bamberg

We bought your "2025 report" in 2020. Everything is fine and very good.

Peter Groot Koerkamp

Account and Business Manager, EFS-Holland BV

Thanks for sending the report it gives us a good global view of the Betaïne market.

Younghwan Choi

Senior Retail Manager, LG Chem

We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.

Mark Irwin

Management Consultant, Level 21

I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.

Rob Kooiker

Group Product Manager HVAC & Fire Protection GMA, Rockwool

I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!

Jason Lee

R&D Director, Seojin

Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.

Akif Moroglu

Strategy & Business Development Director, Dogan Holding

We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.

Lupin Pharmaceuticals, Inc.

Company Headquarters: Mumbai, India Founded: 1968 Workforce: ~18,302 Company Working: Lupin Pharmaceuticals, Inc., a multinational pharmaceutical company, manufactures and distributes drugs. It develops and produces branded and generic formulations, biotechnology goods, and pharmaceutical active components. The company also maintains a pipeline in high-barrier markets such as Inhalation, Biosimilars, and Complex Injectables. The vast majority of the company's sales are generated in the US, followed by India. In addition, Lupin creates generic drugs with added value using its platform technology. Furthermore, the business runs production facilities in Brazil, Mexico, the US, and India together with its subsidiaries.

Starting from

$4,950